Table 1.
Patient Demographics and Pathological Characteristics
| N (%) | ||
|---|---|---|
| All patients | 77 (100) | |
|
| ||
| Clinical Characteristics | ||
|
| ||
| Age – median, years (range) | 63 (38–85) | |
| Age categories (years) | 22–45 | 5 (6) |
| 46–55 | 18 (23) | |
| 56–69 | 35 (45) | |
| 70+ | 19 (25) | |
|
| ||
| Gender | Female | 33 (43) |
| Male | 44 (57) | |
|
| ||
| ECOG Performance Status | 0 | 34 (44) |
| 1 | 42 (55) | |
| >=2 | 1 (1) | |
|
| ||
| Race | White | 52 (68) |
| Hispanic | 16 (21) | |
| Black | 7 (9) | |
| Other | 2 (3) | |
|
| ||
| Symptoms | Any relevant | 70 (91) |
| Pain | 44 (57) | |
| Hematuria | 35 (45) | |
| Weight Loss | 18 (23) | |
| Fever | 6 (8) | |
| Night Sweats | 6 (8) | |
| Other Symptoms | 28 (36) | |
|
| ||
| Pathological Characteristics | ||
|
| ||
| Tumor Size – median, cm (range) | N=68 | 10 (1.8–27) |
|
| ||
| Pathologic Tumor Stage* | T1/T2 | 18 (23) |
| T3 | 42 (55) | |
| T4 | 16 (22) | |
| N (%) | ||
|
| ||
| Pathologic Nodal Stage | N0/Nx | 58 (75) |
| N1 | 19 (25) | |
|
| ||
| Primary Epithelial Histology | ||
| Clear Cell | 56 (73) | |
| Other | 21 (27) | |
|
| ||
| Percent Sarcomatoid Component | 1–24 | 39 (51) |
| 25–49 | 9 (12) | |
| 50–74 | 8 (10) | |
| 75–99 | 12 (16) | |
|
| ||
| Positive Surgical Margins | 15 (19) | |
|
| ||
| Necrosis* | 26 (34) | |
|
| ||
| LVI* | 15 (19) | |
*
Numbers do not always sum to 77 due to missing information 1 each for tumor stage, necrosis, and LVI and 9 for percent sarcomatoid and tumor size